Cargando…

Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey

BACKGROUND AND AIMS: Persons with inflammatory bowel disease (IBD) may be particularly vulnerable to COVID-19 either because of their underlying disease or its management. Guidance has been presented on the management of persons with IBD in the time of this pandemic by different groups. We aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernstein, Charles N, Ng, Siew C, Banerjee, Rupa, Steinwurz, Flavio, Shen, Bo, Carbonnel, Franck, Hamid, Saeed, Sood, Ajit, Yamamoto-Furusho, Jesus K, Griffiths, Anne, Benchimol, Eric I, Travis, Simon, Lopes, Susana, Rubin, David T, Kaplan, Gilaad G, Armstrong, David, Gearry, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454666/ https://www.ncbi.nlm.nih.gov/pubmed/32793973 http://dx.doi.org/10.1093/ibd/izaa202

Ejemplares similares

Sa502 THE FIRST AND SECOND WAVE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A TEMPORAL TREND ANALYSIS
por: Kaplan, Gilaad, et al.
Publicado: (2021)

The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis
por: Kaplan, Gilaad G, et al.
Publicado: (2022)

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
por: Brenner, Erica J., et al.
Publicado: (2020)

Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD
por: Bernstein, Charles N, et al.
Publicado: (2019)

Co-occurrence of Asthma and the Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis
por: Kuenzig, M. Ellen, et al.
Publicado: (2018)

COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States
por: Agrawal, Manasi, et al.
Publicado: (2021)

Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada
por: Kuenzig, M Ellen, et al.
Publicado: (2022)

The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology
por: Kaplan, Gilaad G, et al.
Publicado: (2019)

Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21)
por: Mak, Joyce W. Y., et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD
por: Carroll, Matthew W, et al.
Publicado: (2019)

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors
por: Nguyen, Geoffrey C, et al.
Publicado: (2019)

Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study
por: Murthy, Sanjay K, et al.
Publicado: (2020)

Costs of missed work among employed people with inflammatory bowel disease: a cross-sectional population-representative study.
por: Kuenzig, Ellen, et al.
Publicado: (2022)

The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life
por: Jones, Jennifer L, et al.
Publicado: (2019)

Worldwide post‐marketing safety surveillance experience with tofacitinib in ulcerative colitis
por: Rubin, David T., et al.
Publicado: (2021)

Fr493 DISEASE ACTIVITY IS ASSOCIATED WITH COVID-19 OUTCOMES IN IBD PATIENTS WITH EFFECT MODIFICATION BY AGE
por: Ricciuto, Amanda, et al.
Publicado: (2021)

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada
por: Rose, Keeley L, et al.
Publicado: (2019)

Shifting Health Care Use from Hospitalisations and Surgeries to Outpatient Visits in Children with Inflammatory Bowel Disease: A Population-based Cohort Study from Ontario, Canada
por: Dheri, Aman K, et al.
Publicado: (2021)

Variation in care of patients with elderly-onset inflammatory bowel disease in Ontario, Canada: A population-based cohort study
por: Kuenzig, M Ellen, et al.
Publicado: (2020)

The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization
por: Kuenzig, M Ellen, et al.
Publicado: (2019)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease
por: Benchimol, Eric I, et al.
Publicado: (2021)

Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy
por: Sood, Ajit, et al.
Publicado: (2020)

The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care
por: Kuenzig, M Ellen, et al.
Publicado: (2019)

Budesonide for the Induction and Maintenance of Remission in Crohn’s Disease: Systematic Review and Meta-Analysis for the Cochrane Collaboration
por: Kuenzig, M Ellen, et al.
Publicado: (2018)

Surgery for Inflammatory Bowel Disease Has Unclear Impact on Female Fertility: A Cochrane Collaboration Systematic Review
por: Lee, Sangmin, et al.
Publicado: (2020)

The four epidemiological stages in the global evolution of inflammatory bowel disease
por: Kaplan, Gilaad G., et al.
Publicado: (2020)

ISDN explained: worldwide network and applications technology
por: Griffiths, John M
Publicado: (1992)

Diagnosis and Treatment of Urticaria and Angioedema: A Worldwide Perspective
por: Sánchez-Borges, Mario, et al.
Publicado: (2012)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care
por: Jones, Jennifer L, et al.
Publicado: (2021)

Insular threat associations within taxa worldwide
por: Leclerc, Camille, et al.
Publicado: (2018)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life
por: Graff, Lesley A, et al.
Publicado: (2021)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Epidemiology—The Trends of Disease Over Time
por: Coward, Stephanie, et al.
Publicado: (2021)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines—Biology, Current Evidence and Recommendations
por: Murthy, Sanjay K, et al.
Publicado: (2021)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD
por: Bernstein, Charles N, et al.
Publicado: (2021)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications
por: Targownik, Laura E, et al.
Publicado: (2021)

Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients
por: Ricciuto, Amanda, et al.
Publicado: (2021)

Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases
por: Benchimol, Eric I, et al.
Publicado: (2017)

Defence dentistry: an occupationally focused health service with worldwide deployable capability
por: Armstrong, Sarah, et al.
Publicado: (2021)

Insights into the role of cannabis in the management of inflammatory bowel disease
por: Picardo, Sherman, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1ijgtd3pct4p67mdushjagjvog